TNF-α Down-Regulates Type 1 Cytokines and Prolongs Survival of Syngeneic Islet Grafts in Nonobese Diabetic Mice

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6298-6303

  Rabinovitch, Alex ^a   Suarez Pinzon, Wilma L ^a   Sorensen, Ole ^a   Rajotte, Ray V ^a   Power, Robert F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOBREEDING RAT; BIOSYNTHESIS; DOWN REGULATION; DRUG EFFECT; FEMALE; GENETICS; GRAFT SURVIVAL; IMMUNOLOGY; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; ISOGRAFT; LYMPHOCYTE SUBPOPULATION; METABOLISM; METHODOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; RAT; SPLEEN; TH1 CELL; TRANSPLANTATION;

ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 1; DOWN-REGULATION; FEMALE; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; IMMUNOPHENOTYPING; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED NOD; RATS; RATS, INBRED BB; RNA, MESSENGER; SPLEEN; TH1 CELLS; TRANSPLANTATION, ISOGENEIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031573621     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Sibley, R. K., D. E. R. Sutherland, F. Goetz, and A. F. Michael. 1985. Recurrent diabetes mellitus in the pancreas iso- and allograft. Lab. Invest. 53:132.
2. Tyden, G., F. P. Reinholt, G. Sundkvist, and J. Bolinder. 1996. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N. Engl. J. Med. 335:860.
3. Crisa, L., J. P. Mordes, and A. A. Rossini. 1992. Autoimmune diabetes in the BB rat. Diabetes Metab. Rev. 8:9.
4. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD mouse and related strains. Adv. Immunol. 51:285.
5. Rabinovitch, A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 43: 613.
6. Mandrup-Poulsen, T., K. Bendtzen, C. A. Dinarello, and J. Nerup. 1987. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell toxicity. J. Immunol. 139:4077.
7. Campbell, I. L., A. Iscaro, and L. C. Harrison. 1988. IFN-γ and tumor necrosis factor-α: cytotoxicity to murine islets of Langerhans. J. Immunol. 141:2325.
8. Pukel, C., H. Baquerizo, and A. Rabinovitch. 1988. Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37:133.
9. Rabinovitch, A., W. Sumoski, R. V. Rajotte, and G. L. Warnock. 1990. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J. Clin. Endocrinol. Metab. 71:151.
10. Higuchi, Y., P. Herrera, P. Muniesa, J. Huarte, D. Belin, P. Ohashi, P. Aichele, L. Orci, J.-D. Vassalli, and P. Vassali. 1992. Expression of a tumor necrosis factor α transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176:1719.
11. Guerder, S., D. E. Picarella, P. S. Linsley, and R. A. Flavell. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91:5138.
12. Held, W., H. R. MacDonald, I. L. Weissman, M. W. Hess, and C. Mueller. 1990. Genes encoding tumor necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc. Natl. Acad. Sci. USA 87:2239.
13. Pilström, B., L. Björk, and J. Böhme. 1997. Monokine-producing cells predominate in the recruitment phase of NOD insulitis while cells producing Th1-type cytokines characterize the effector phase. J. Autoimmun. 10:147.
14. Jiang, Z., and B. A. Woda. 1991. Cytokine gene expression in the islets of the diabetic BioBreeding/Worcester rat. J. Immunol. 146:2990.
15. Yang, X.-D., R. Tisch, S. M. Singer, Z. A. Cao, R. S. Liblau, R. D. Schreiber, and H. O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995.
16. Jacob, C. O., S. Asiso, S. A. Michie, H. O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin-1. Proc. Natl. Acad. Sci. USA 87:968.
17. Satoh, J., H. Seino, T. Abo, S.-I. Tanaka, S. Shintani, S. Ohta, T. Sawai, T. Nobunga, T. Oteki, K. Kumagai, and T. Toyota. 1989. Recombinant human tumor necrosis factor-α suppresses autoimmune diabetes in nonobese diabetic mice. J Clin. Invest. 84:1345.
18. Satoh, J., H. Seino, S. Shintani, S.-I. Tanaka, T. Ohteki, T. Masada, T. Nobunaga, T. Oteki, K. Kumagai, and T. Toyota. 1990. Inhibition of type I diabetes in BB rats with recombinant human tumor necrosis factor-α. J. Immunol. 145:1395.
19. Lapchak, P. H., L. J. Guilbert, and A. Rabinovitch. 1992. Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund's adjuvant: a possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes. Clin. Immunol. immunopathol. 65:129.
20. Rabinovitch, A., W. L. Suarez-Pinzon, P. H. Lapchak, A. Meager, and R. F. Power. 1995. Tumor necrosis factor mediates the protective effect of Freund's adjuvant against autoimmune diabetes in BB rats. J. Autoimmun. 8:357.
21. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34.
22. Hancock, W. W., M. Polanski, J. Zhang, N. Blogg, and H. L. Weiner. 1995. Suppression of insulitis in nonobese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β. and prostaglandin E. Am. J. Pathol. 147:1193.
23. Wang, T., B. Singh, G. L. Warnock, and R. V. Rajotte. 1992. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 41:114.
24. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and K. T. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
25. Rabinovitch, A., W. L. Suarez-Pinzon, O. Sorensen, R. C. Bleackley, R. F. Power, and R. V. Rajotte. 1995. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Transplantation 60:368.
26. Rabinovitch, A., W. L. Suarez-Pinzon, O. Sorensen, R. C. Bleackley, and R. F. Power. 1994. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol 154:4874.
27. Kennedy, M. K., D. S. Torrance, K. S. Picha, and K. M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496.
28. Gerasimidi, A., K. C. F. Sheehan, R. D. Schreiber, and P. E. Lacy. 1993. Tumor necrosis factor-α prevents rejection of islet xenografts (rat to mouse). Diabetes 42:651.
29. Gordon, C., and D. Wofsy. 1990. Effects of recombinant murine tumor necrosis factor-α on immune function. J. Immunol. 144:1753.
30. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
31. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575.
32. Campbell, I. L., T. W. H. Kay, L. Oxbrow, and L. C. Harrison. 1991. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:739.
33. Shehadeh, N., F. LaRosa, and K. J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:291.
34. Rothe, H., A. Faust, U. Schade, R. Kleeman, G. Bosse, T. Hibino, S. Martin, and H. Kolb. 1994. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-γ, but not of interleukin-4. Diabetologia 37:1154.
35. Rabinovitch, A., O. Sorensen, W. L. Suarez-Pinzon, R. F. Power, R. V. Rajotte, and R. C. Bleackley. 1994. Analysis of cytokine mRNA expression in syngeneic islet grafts of NOD mice: interleukin 2 and interferon gamma mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 37:833.
36. Muir, A., A. Peck, M. Clare-Salzler, Y.-H. Song, J. Cornelius, R. Luchetta, J. Krischer, and N. Maclaren. 1995. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription. J. Clin. Invest. 95:628.
37. Trembleau, S., G. Penna, S. Gregori, T. Magram, M. K. Gately, and L. Adorini. 1995. The role of endogenous IL-12 in the development of spontaneous diabetes in NOD mice. Autoimmunity 21:23.
38. Rothe, H., V. Burkart, A. Faust, and H. Kolb. 1996. Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 39:119.
39. Zipris, D., D. L. Greiner, S. Malkani, B. Whalen, J. P. Mordes, and A. A. Rossini. 1996. Cytokine gene expression in islets and thyroids of BB rats: IFN-γ and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J. Immunol. 156:1315.
40. Fox, C. J., and J. S. Danska. 1997. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J. Immunol. 158:2414.
41. Wogensen, L., M. S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β-cells in nonobese diabetic mice. J. Exp. Med. 179:1379.
42. + T-cells in syngeneic islet grafts in NOD mice produce interferon-γ during β-cell destruction. Diabetes 45:1350.